Drug Type Small molecule drug |
Synonyms XNTR 936, XNTR-936 |
Target |
Mechanism AR antagonists(Androgen Receptor antagonists), PARP inhibitors(Poly (ADP-Ribose) polymerase inhibitors), STAT inhibitors(STAT transcription factors inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - | |
Metastatic castration-resistant prostate cancer | Discovery | US | 30 Jan 2022 | |
Triple Negative Breast Cancer | Discovery | US | 30 Jan 2022 |